chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Aches/ Pain; Sore throat; Bad cough; Felt like someone sitting on his chest; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches/ Pain), OROPHARYNGEAL PAIN (Sore throat), COUGH (Bad cough), CHEST DISCOMFORT (Felt like someone sitting on his chest) and PYREXIA (Fever) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Pneumonectomy (half of his lung was removed.). Concurrent medical conditions included Cancer. Concomitant products included CARBAMAZEPINE (TEGRETOL), GABAPENTIN (NEURONTIN), LISINOPRIL, CARVEDILOL, ACETYLSALICYLIC ACID (BABY ASPIRIN) and FUROSEMIDE for an unknown indication.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced PAIN (Aches/ Pain), OROPHARYNGEAL PAIN (Sore throat), COUGH (Bad cough) and CHEST DISCOMFORT (Felt like someone sitting on his chest). On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PAIN (Aches/ Pain), OROPHARYNGEAL PAIN (Sore throat), COUGH (Bad cough), CHEST DISCOMFORT (Felt like someone sitting on his chest) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications and treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: significant due to batch number,and event start date were provided.
Administered a proquad in addition to a varicella vaccine.  Due to patient moving a partial dose of varicella was given.
FEVER UP TO 103.8 WITHIN < 24 HOURS OF ADMINISTRATION AND LASTED FOR 72 HOURS, STILL HAS LOW GRADE FEVER TO 100 DEGREES F. ON 4TH DAY AFTER ADMINISTRATION, ALSO HAS REDNESS, SWELLING AND INCREASED WARMTH OF RIGHT THIGH MEASURING 11 X 8.5 CM AND STILL PRESENT 4 DAYS AFTER ADMINISTRATION, TREATED FOR THIGH CELLULITIS WITH AUGMENTIN 600/42.9/5 ML- ONE TEASPOON BID X 10 DAYS, PATIENT ALSO EXPERIENCED "BLOOD SUGAR" SEIZURE (FROM PRESUMED HYPOGLYCEMIA) PER MOM 1 DAY AFTER THE INJECTION WAS GIVEN. HAS HISTORY OF THESE BUT HAD NOT HAD ONE FOR 3 YEARS. CHILD WAS PALE AND WEAK WITH HIGH FEVER, HIVES ON LIP AND BACK PEA-SIZE 24 HOURS AFTER INJECTION, WENT AWAY WITH BENADRYL. PAIN WITH WALKING FROM THIGH CELLULITIS.
Why is my left are still sore from the 3rd dose Pfizer vaccine (from January 2022 from pharmacy).  I can hear the crunching when I move my arm. There is No swelling at all just Stiffness and soreness and I have to lift my arm up with my right hand to use it.  Why? No I have not slept the wrong way, I have not left anything too heavy, I cannot left anything without using my right hand to assist my left arm to move. I am suppose to get my 4th Pfizer vaccine shot in June 2022.  What is wrong with my arm? My doctors say it is normal...NO IT IS NOT-for 5 months and I still have stiffness and soreness REALLY!!   Optional Information
Shot given in (R) deltoid - IM, pt tolerated injection well, on 10/23/12. Then seen again 11/9/2012 - she reports flu shot caused stress, arm still sore, internally. She also reports stress related to job-being eliminated. She has appt with Primary Care MD next week.
On her way to bathroom felt dizzy and lost balance (swirled around); fell broke shoulder and wrist taken to ER took a while for heart beat to normalize. Now wearing a cast ever since vax has vertigo when sit down or gets up, vertigo gradually improving.
Dose Number: 1 administered on 02-Nov-2021 and Dose Number: 2 administered on 17-Feb-2022; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose Number: 1 administered on 02-Nov-2021 and Dose Number: 2 administered on 17-Feb-2022) in a 61-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Nov-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-Feb-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2022,  after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose Number: 1 administered on 02-Nov-2021 and Dose Number: 2 administered on 17-Feb-2022). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose Number: 1 administered on 02-Nov-2021 and Dose Number: 2 administered on 17-Feb-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2022-568301, MOD-2022-568300 (Patient Link).
By 7:00 p.m. the same day as the 2nd shot Bones were achy, fever, headache, tired, dizzy, no appetite!!!! Today the same!!! day 2 April 22, 2021.
1st dose of vaccine, 04Aug, had bleeding on the site of administration; resulting to hematoma on the left arm; experienced flu like symptoms; dry cough; nasal congestion; headache; body ache; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Aug2021 15:00 (Lot number: F87484) at the age of 53 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE HAEMORRHAGE (non-serious), outcome "not recovered", described as "1st dose of vaccine, 04Aug, had bleeding on the site of administration"; HAEMATOMA (non-serious), outcome "not recovered", described as "resulting to hematoma on the left arm"; INFLUENZA LIKE ILLNESS (non-serious), outcome "not recovered", described as "experienced flu like symptoms"; COUGH (non-serious), outcome "not recovered", described as "dry cough"; NASAL CONGESTION (non-serious), outcome "not recovered", described as "nasal congestion"; HEADACHE (non-serious), outcome "not recovered", described as "headache"; PAIN (non-serious), outcome "not recovered", described as "body ache"; FATIGUE (non-serious), outcome "not recovered", described as "fatigue". Therapeutic measures were not taken as a result of vaccination site haemorrhage, haematoma, influenza like illness, cough, nasal congestion, headache, pain, fatigue.   Additional information: Patient did not receive any other vaccines within 4 weeks to the COVID vaccine but received other unspecified medications within 2 weeks of the vaccination. Patient received no treatment for the events and had no known allergies. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Feeling a little rough; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 27Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Feb2021, outcome "unknown", described as "Feeling a little rough".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever; Felt horrible; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MALAISE (Felt horrible) and PAIN (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), MALAISE (Felt horrible) and PAIN (Body aches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), MALAISE (Felt horrible) and PAIN (Body aches) outcome was unknown.            Concomitant medications were not reported.
INSOMNIA,JOINT STIFFNESS,KIDNEY FAILURE,PROTERNURA,LIBIDO LOSS,MEMORY DIFFICULTY,MEMORY LOSS,TROUBLE REMENBERING RECENT INFORMATION OR EVENT, SHORT TERM MEMORY LOSS,INCREASE IN FORGETFULNESS, MENSTRUAL ABNORMALITIES,TASKS SIMULTANEOUSLY,NEUROLIGICAL DESPRESSION,MOOD SWINGS,MOOD ANXIOUS,MOOD ANGRY,MOOD IRRITABLE,NECK RIGID,NERVOUSNESS ANXIETY,NUMBNES AND TINGLING FINGERS,LOWER BACK PAIN,RIGHT SHOULDER/HIPS AND LEGS PAIN,KNEES AND HIPS PAIN,EAR PAIN,FREQUENT BACK PAIN,PAINS IN FEET LIKE ELECTRICAL SHOCKS,PALPITATIONS ABNORMAL,REFLUX,SHORTNESS OF BREATH,ROTATING HOT AND COLD SPELLS,SINUSITIS,SKIN ITCHING,ITCHING DRY AND FLAKY SKIN,JOINT ACHE,FREQUENT AGITATION,AMNESIA,BLOOD ANEMIA,MOOD ANXIETY, ASTHMA,LOOS OF BALANCE,VERTIGO AND DIZZINESS,BLOATING,HIGH BLOOD PRESSURE,BOWELS IRRITABLE,RESPIRATORY PROBLEM,BRONCHITIS,BURSITIS,DIFFICULTY TO CONCENTRATE,LOSS OF CONCENTRATION,CONSTIPATION,COUGH FREQUENT,CRAMPS LEG,HANDS AND BACK,DEPRESSION,FREQUENR INDIGESTION,DIGESTIVE PROBLEM,BALANCE DIZZINESS, SKIN ECZEMA,ENERGY LOSS, ENERGY LOW LEVELS,HAIR FALLING OUT,HEADACHES,RINGING IN EARS,POOR TOLERANCE FOR LOUD NOISES,HEMORRAGE VAGINAL, HOT FLASHES,HYPERTENSION,PUSTULE SORES ON SCALP,FEEL NOT REFRESHED UPON WAKING UP,SHIFTING SLEEP PATTERNS,UNABLE TO SLEEP FLAT WITHOUT MEDICATION,INAPPROPRIATELY SWEATING,SWELLING JOINTS,KNEES AND ANKLES,SWOLLEN GLANDS,SWOLLEN LUMP IN NECK BELOW EAR BEHIND JAW,THIRST INCREASED,VERTIGO, VOICE ALTERATION,WEIGHT GAIN, WALKING PROBLEM,FREQUENT VOMITING...
had a heart and upper gastrointestinal reaction to the purple cap Pfizer Covid-19 vaccine; had a heart and upper gastrointestinal reaction to the purple cap Pfizer Covid-19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GASTROINTESTINAL DISORDER (non-serious), CARDIAC DISORDER (non-serious), outcome "unknown" and all described as "had a heart and upper gastrointestinal reaction to the purple cap Pfizer Covid-19 vaccine". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
not feeling well/just not feeling well; tired; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well/just not feeling well) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced MALAISE (not feeling well/just not feeling well) and FATIGUE (tired). At the time of the report, MALAISE (not feeling well/just not feeling well) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported by the reporter. No concomitants medicines were reported.
Patient had redness, swelling, and tenderness on the day after the vaccine (9/1/08) along with a fever. Patient went to her doctor the following day, and stated she had an allergy to niacin. Her fever had subsided and she was given medication for allergic reaction by her doctor. The patient started feeling bad again with a high fever and went to the BAMC ER, where the doctor said she had an infection on the arm with the shingles vaccine. She had received a PPV23 vaccine on the opposite arm with no adverse reactions. Patient is on anti-bx, and as of 9/4/08, states her arm is feeling better.
Arm started hurting 12 hours after shot. When I woke up in the morning I had chills, headache, diarrhea and nausea  (although I never vomited). Went back to bed at noon because I couldn?t get warm on the couch. Had nightgown, sweater, heating pad, blankets, plus a wool Afghan. Slept from noon until 8:45 AM the next day with a few bathroom breaks and Tylenol. Still having headache today which is Sunday. Had the shot Thursday morning. Had similar, but worse reaction to the second shingle shot.
VACCINE ADMINISTERED OUTSIDE OF THE RECOMMENDED HOLD TIME; INCORRECT STORAGE OF DRUG; This spontaneous report received from a pharmacist concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 09-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-SEP-2021, the patient experienced vaccine administered outside of the recommended hold time. On 09-SEP-2021, the patient experienced incorrect storage of drug. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered outside of the recommended hold time and incorrect storage of drug was not reported. This report was non-serious. This case, from the same reporter is linked to 20210924112.
This spontaneous report as received from a nurse practitioner refers to a 12 month old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 15-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion (incorrect product storage). No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Shortness of breath, swelling (legs and feet), fever, really red and fatigue. Started with achiness all over. High fever of 104.9. Extreme bone pain for 16 days. Diagnosed with CMV. Started a few days after booster vaccine. On January 18th got really sick.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient was enrolled in the Varicella Zoster Virus Identification. Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine strain. Patient's medical history, concurrent conditions and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (lot number, dose and route were not reported). On an unknown date the patient experienced chickenpox type rash. The outcome of the event was not reported. The relatedness between the vent and (Oka/Merck) VARIVAS was not reported. Additional information has been requested.
About 30 minutes after getting the vaccine patient stated that she felt like her left pinky finger was tingling and started itching.  Pt seen 1 hour and 15 minutes after injection was given and stated that she feels better now, but still some less sensation on left pinky than the rest of her arm and hand.  Pt declined treatment in clinic and stated that she  was going to take Zyrtec.
Vaccinated on the tricepts and it hit a bone; A spontaneous report was received from a consumer who was also a75-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was vaccinated on the triceps and it hit a bone.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 25 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 25 Jan 2021, the patient felt like the vaccine was not administered correctly. He was vaccinated on the triceps, and it hit a bone.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event, vaccinated on the triceps and it hit a bone, was resolved on 25 Jan 2021.; Reporter's Comments: This case concerns a75-years-old male patient who received his first of two planned doses of mRNA-1273 (Lot number: 025L20A) intramuscularly for prophylaxis of COVID-19 infection. and was vaccinated on the triceps and it hit a bone. There were no reported adverse events at the associated with the event of vaccinated on the triceps and it hit a bone.
Information has been received from a physician concerning a 6 month old male infant with no known allergies or pertinent medical history who on 12-FEB-2008 was vaccinated orally with third dose of ROTATEQ. Concomitant vaccinations included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown), Hib conj vaccine (OMPC) (manufacturer unknown) and PREVNAR. Subsequently, after receiving the third dose of ROTATEQ the patient developed intussusception. On 29-FEB-2008 the patient was hospitalized for 5 days. The patient was discharged on 05-MAR-2008. At the time of the report the patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.  8/21/2008 MR received for ER observation visit 3/2/2008 with DX:  Ileocecal Intussusception.  Pt presented with 3 day hx of inconsolable crying, emesis with feeds, abdominal pain and no BM or flatus.  PE (+) for mild distress, abdominal distention. IS reduced by Air Contrast Enema.  Post procedure pt taking po well and d/c.
Rash started on legs then spread to arms then face. Some scabbed, some new, itchy and red. Placed on BACTROBAN and clindamycin as appeared superinfected. Approximately 6 weeks after VARIVAX given.
12.5cm x 6cm area of erythema, very warm to touch, nontender, nonpruritic. Benadryl OTC
Developed increased left eye lacrimation the morning of 3/13. Then received Moderna vaccine at 11:30 AM. Then developed facial droop, loss of nasolabial fold, increased lacrimation of left side. Was evaluated on 3/18/2021 with diagnosis of Bell palsy.
Chickenpox illness despite vaccination, papular and vesicular lesions - face, trunk, upper arm.
Induration at (L) thigh injection site from DtaP. (about 4 x 6 inches): Site improving without meds or ice.
Last week I apparently contracted the sar-cov-2 virus/tested positive; Last week I apparently contracted the sar-cov-2 virus/tested positive; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date in Jan2021 as dose 1, single, and then dose 2 via an unspecified route of administration on an unspecified date Jan2021 (Batch/Lot number was not reported, Expiry date: unknown) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that last week the patient apparently contracted the SAR-COV-2 virus and had been quite sick since then. The patient had tested positive and had GI issues, fever, congestion, lethargy, chest pains, and shallow breathing. The patient was confounded and frustrated. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date in Jul2021. Outcome of the events was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Resident with c/o Shortness of breath become non responsive .  911 called, ,Cpr initiated , resident expired
Headache within hr, fever, weakness, tired, red spot 1" x 2" on arm at injection site with sm. blister.
On 01/31/2001 within a few hours of vaccination the patient developed vesicles. The following day the patient developed 'many vesicles' and was seen by a nurse practitioner. Additional information has been requested.
Client reports symptoms started 8-13-22 @ 5:00am, awoke chills, pain of neck,  head, and back at that time took 1000mg Tylenol fever was 103.6, took luke warm bath tempt went down to 100, but tempt went back up to 102 she started throwing up for several hours. Fever went down to normal @4:30. On 8-14-22 her arm was painful at injection site did have fever of 101 8-15-22 2:30 client called reports painful arm enc her to contact her PCP.
Splotchy rash on chest, arms, neck, and legs. The rash was strongest on my chest. No itching. Slowly went away by 6/7/17. Took BENADRYL at night.
1/8/20 Per triage: "Received vaccines 1/3/20. Her left arm where she got her HPV the day after started with some redness. The redness over the past few days has worsened and is almost the whole length of her upper arm, not going past either joint. She also broke out in hives just on the upper portion of arm.  Mom gave benadryl, hives went away, but came back."  Patient presents today with her mother. Patient was seen by Dr. pediatrics on 1/3/2020 for her 11 year WCC. Patient received her meningococcal and HPV vaccinations in her LEFT deltoid. Mother reports redness on the patient LEFT arm that appeared the day following the vaccinations. Mother reports the redness exacerbated and that the patient developed hives on the upper portion of her LEFT arm. Patient denies the affected area in painful. She notes the affected area occasionally itches. Mother reports treating the patient's symptoms with benadryl. Mother reports benadryl temporarily improved the patient's symptoms but notes the hives later returned.   Mother reports the patient has a history of hives. Patient reports getting hives after rubbing her skin in the past.
26FEB94 1030PM lt thigh swollen to about size of softball, warm to touch, fever 101, vomit x 2 gave warm bath, cold compress, APAP; MD contacted;
Swollen arm; Rash on the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE URTICARIA (Rash on the site of the injection) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE URTICARIA (Rash on the site of the injection). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE URTICARIA (Rash on the site of the injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.